The Workshop will introduce and explain the new WIPO Alternative Dispute Resolution (ADR) Options that have been developed by the WIPO Arbitration and Mediation Center to assist parties in resolving disputes in the life sciences sector.
The current pandemic crisis has placed significant strain on existing and new collaborations across the life sciences sector. As part of the WIPO suite of support measures to assist member states in addressing the COVID-19 pandemic, the WIPO Center has extended its ADR services to include new ADR options. WIPO’s ADR services now include options to facilitate contract negotiation and dispute resolution for actors operating in the pharmaceutical, biosciences, medical devices and chemical industries. This new offering follows extensive consultation with experts, including experienced WIPO arbitrators and mediators.
The workshop is supported by Licensing Executives Society International (LESI), European Industrial Research Management Association (EIRMA), International Association for the Protection of Intellectual Property (AIPPI) and, International Federation of Pharmaceutical Manufactures and Associations (IFPMA).
Read more & register!